Shire's oncology exit weighs on potential Takeda bid

Shire's oncology exit weighs on potential Takeda bid

Submitted by admin on April 17, 2018 - 9:37am
Source: 
Biopharma Dive
News Tags: 
Shire
oncology
Takeda
M&A
Servier
Headline: 
Shire's oncology exit weighs on potential Takeda bid
snippet: 

Shire plc is backing out of cancer drugs, announcing Monday the sale of its oncology business to French pharma Servier S.A.S. for $2.4 billion in cash.

Do Not Allow Advertisers to Use My Personal information